| Name | Title | Contact Details |
|---|
Kerry develops, manufactures and delivers innovative taste systems, functional and nutritional ingredients and integrated solutions for the Food, Beverage and Pharmaceutical markets. Customers derive maximum synergies through utilizing Kerry`s broad and deep range of food technologies, application capabilities and processing expertise.
Pladis is a global biscuit and confectionery company with operations in 120 countries across Europe, the Middle East, Africa, Asia and the Americas. The company is owned by Yildiz Holding, the largest food company in CEEMEA, and combines three centuries of baking and confectionery expertise by bringing together its iconic Godiva, McVitie`s and Ulker brands.
Corporate catering & lunch delivery for the modern office.
CentralStar serves dairy and beef producers in Wisconsin, Michigan, and Indiana, with additional DHI territory in surrounding states. Full-time employee team me
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.